Gilead Shares Early Results Of Remdesivir Trial In COVID-19 Patients

Gilead Shares Early Results Of Remdesivir Trial In COVID-19 Patients

Newsy

Published

Watch VideoBiotech company Gilead Sciences released testing results Monday that show certain COVID-19 patients improved after receiving the drug remdesivir. 

Nearly 600 hospitalized patients who had moderate pneumonia but did not need oxygen support were randomly assigned to be treated with remdesivir for five days, along...

Full Article